{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Celator Pharmaceuticals", "item": "https://www.patentleaderboard.com/2021/company/celator-pharmaceuticals"}, {"@type": "ListItem", "position": 4, "name": "Jeffrey Tyner", "item": "https://www.patentleaderboard.com/2021/inventor/fl:je_ln:tyner-3"}]}

Home › 2021 › Celator Pharmaceuticals › Jeffrey Tyner

Jeffrey Tyner — 1 Patent in 2021

CPCelator Pharmaceuticals: 1 patents #2 of 13Top 20%

Portland, OR: #794 of 1,855 inventorsTop 45%

Oregon: #1,702 of 4,388 inventorsTop 40%

Overall (2021): #407,764 of 548,734Top 75%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date
10927418	Assays and methods for selecting a treatment regimen for a subject with leukemia	Max GORDON, Paul Tardi, Lawrence Mayer	2021-02-23

Jeffrey Tyner — 1 Patent in 2021

Issued Patents 2021

Patent Widget